IPO Monitor
Subscribe Login Login About Us Contact Us Help
Latest IPO News (beta)

[ All Markets | U.S. | Canada | Europe | China ]


BRIEF-Replimune Group Inc files for IPO of up to $100 mln – SEC filing

* REPLIMUNE GROUP INC FILES FOR IPO OF UP TO $100 MILLION – SEC FILING. * REPLIMUNE GROUP INC SAYS IT INTENDS TO APPLY TO HAVE ITS COMMON STOCK LISTED ON NASDAQ UNDER THE SYMBOL "REPL" * REPLIMUNE GROUP INC SAYS J.P.MORGAN, LEERINK PARTNERS, BMO CAPITAL MARKETS ARE AMONG UNDERWRITERS TO IPO. * REPLIMUNE GROUP INC SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE.
[ Fidelity at 2018-06-22 18:28:23 ]


BRIEF-Rubius Therapeutics Inc Files For IPO Of Up To $200 Mln

* RUBIUS THERAPEUTICS INC FILES FOR IPO OF UP TO $200 MILLION – SEC FILING. * RUBIUS THERAPEUTICS INC SAYS IT INTENDS TO APPLY TO HAVE ITS COMMON STOCK LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL "RUBY" * RUBIUS THERAPEUTICS INC SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE.
[ Fidelity at 2018-06-22 14:02:50 ]


Constellation Pharmaceuticals Files for $86.3 Mln IPO on Nasdaq

Constellation Pharmaceuticals has filed to raise up to $86.3 million through an initial public offering to list on the Nasdaq Global Market under the symbol CNST, according to its prospectus on Friday. JPMorgan, Jefferies, BMO and Oppenheimer are among the underwriters. MT Newswires does not provide investment advice.
[ Fidelity at 2018-06-22 13:44:10 ]


BRIEF-Allakos Inc Files For IPO Of Up To $75 Million

Allakos Inc: * ALLAKOS INC FILES FOR IPO OF UP TO $75 MILLION – SEC FILING. * ALLAKOS INC SAYS IT INTENDS TO APPLY TO HAVE ITS COMMON STOCK LISTED ON NASDAQ GLOBAL SELECT MARKET UNDER THE SYMBOL "ALLK" * ALLAKOS INC SAYS GOLDMAN SACHS & CO. LLC, JEFFERIES, WILLIAM BLAIR ARE AMONG UNDERWRITERS TO IPO.
[ Fidelity at 2018-06-22 13:38:40 ]


BRIEF-Crinetics Pharmaceuticals Files For IPO Of Up To $86.3 Mln

Crinetics Pharmaceuticals Inc: * CRINETICS PHARMACEUTICALS INC FILES FOR IPO OF UP TO $86.3 MILLION – SEC FILING. * CRINETICS PHARMACEUTICALS INC SAYS IT INTENDS TO APPLY TO HAVE ITS COMMON SHARES LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL "CRNX" * CRINETICS PHARMACEUTICALS INC SAYS J.P. MORGAN, LEERINK PARTNERS, PIPER JAFFRAY ARE AMONG UNDERWRITERS TO IPO.
[ Fidelity at 2018-06-22 13:33:35 ]


BRIEF-Constellation Pharmaceuticals Files For IPO Of Up To $86.3 Mln

Constellation Pharmaceuticals Inc: * CONSTELLATION PHARMACEUTICALS INC FILES FOR IPO OF UP TO $86.3 MILLION – SEC FILING. * CONSTELLATION PHARMACEUTICALS INC SAYS IT INTENDS TO APPLY TO HAVE ITS COMMON STOCK LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL "CNST" * CONSTELLATION PHARMACEUTICALS INC SAYS J.P. MORGAN, JEFFERIES, BMO CAPITAL MARKETS ARE AMONG UNDERWRITERS TO IPO.
[ Fidelity at 2018-06-22 13:26:29 ]


Twelve Seas Investment Raises $180.0 Mln in IPO

Twelve Seas Investment Company(TWLVU) said Friday that it closed its initial public offering of 18.0 million units at $10.00 each, raising gross proceeds of $180.0 million. Each unit consists of one common share, one warrant to purchase a common share at $11.50 each, and one right to receive one-tenth of a common share upon consummation of the company's initial business combination.
[ Fidelity at 2018-06-22 13:07:35 ]


BRIEF-Cango Inc Files For U.S. IPO Of Up To $300 Million

Cango Inc: * CANGO INC FILES FOR U.S. IPO OF UP TO $300 MILLION – SEC FILING. * CANGO INC SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NYSE UNDER THE SYMBOL "CANG" * CANGO INC SAYS MORGAN STANLEY, BOFA MERRILL LYNCH, GOLDMAN SACHS L.L.C ARE AMONG UNDERWRITERS TO IPO. * CANGO INC SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE Source text:
[ Fidelity at 2018-06-22 10:11:05 ]


Stock Move: ElectroCore Shares Surge 23% in Nasdaq Debut

ElectroCore, Inc.(ECOR) shares surged more than 23% to $18.45 during the stock's first trading day on the Nasdaq Global Select Market. The bioelectronics medicine company priced its initial public offering of 5.2 million shares of common stock at $15 per share. The underwriters have been granted a 30-day option to purchase up to 780,000 additional shares.
[ Fidelity at 2018-06-22 08:59:19 ]


BRIEF-IC Power Ltd Files To Withdraw IPO Plans

IC Power Ltd(ICP): * IC POWER LTD FILES TO WITHDRAW IPO PLANS - SEC FILING. * IC POWER LTD SAYS IT HAD PREVIOUSLY FILED FOR U.S. IPO OF UP TO $100 MILLION IN AUGUST 2015 Source text : Further company coverage:
[ Fidelity at 2018-06-22 07:03:44 ]


BJ's Wholesale is going public: 6 things to know about the Costco rival

By Tonya Garcia and Ciara Linnane, MarketWatch. BJ's private-equity owners will retain control of a company with margins that lag rivals. BJ's Wholesale Club, operator of 215 warehouse clubs across 16 states largely along the U.S.' s eastern seaboard, is planning an initial public offering, returning to the public markets after a seven-year spell as a private company.
[ Fidelity at 2018-06-22 03:58:43 ]


Medical Device Maker electroCore Prices IPO at $15/Share

electroCore, Inc., a bioelectronics medicine company, said late Thursday that it priced its initial public offering of 5.2 million shares of common stock at a public offering price of $15 per share. The underwriters have been granted a 30-day option to purchase up to 780,000 additional shares. The offering is expected to close on or about June 26, subject to customary closing conditions.
[ Fidelity at 2018-06-22 01:29:28 ]


BRIEF-Electrocore Inc Announces Pricing Of Initial Public Offering

* ELECTROCORE, INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING. * ELECTROCORE INC- PRICING OF ITS INITIAL PUBLIC OFFERING OF 5.2 MILLION SHARES OF COMMON STOCK AT A PUBLIC OFFERING PRICE OF $15.00 PER SHARE Source text for Eikon:
[ Fidelity at 2018-06-21 18:26:51 ]


electroCore, Inc. Announces Pricing of Initial Public Offering


[ GlobeNewswire at 2018-06-21 17:42:00 ]


U.S. medical device firm electroCore IPO price set at $15/shr

U.S. medical device maker electroCore Llc's initial public offering is expected to price at $15 per share, Chief Executive Officer Frank Amato told Reuters on Thursday. ElectroCore, which is backed by the venture capital arm of Merck & Co (MRK), is set to debut on the Nasdaq on Friday under the ticker symbol "ECOR".
[ Fidelity at 2018-06-21 17:00:16 ]


Establishment Labs Files for $57.5 Mln IPO on Nasdaq

Establishment Labs has filed for an initial public offering to raise $57.5 million through a listing on the Nasdaq Capital market, its preliminary prospectus showed on Thursday. The medical technology company focused on breast aesthetics and reconstruction plans to trade under the symbol ESTA. Jefferies, Cowen and BTIG are the underwriters. MT Newswires does not provide investment advice.
[ Fidelity at 2018-06-21 14:41:07 ]


BRIEF-Establishment Labs Files For IPO Of Up To $57.5 Million

Establishment Labs Holdings Inc: * ESTABLISHMENT LABS HOLDINGS INC FILES FOR IPO OF UP TO $57.5 MILLION – SEC FILING. * ESTABLISHMENT LABS HOLDINGS INC - INTEND TO APPLY TO LIST OUR COMMON SHARES ON THE NASDAQ CAPITAL MARKET UNDER THE TRADING SYMBOL “ESTA. * ESTABLISHMENT LABS HOLDINGS INC - FOR IPO, JOINT BOOK-RUNNING MANAGERS ARE JEFFERIES, COWEN & LEAD MANAGER IS BTIG.
[ Fidelity at 2018-06-21 14:30:51 ]


BRIEF-IPL Plastics Files Final Prospectus And Announces Pricing For Initial Public Offering

IPL Plastics Inc: * IPL PLASTICS INC. FILES FINAL PROSPECTUS AND ANNOUNCES PRICING FOR INITIAL PUBLIC OFFERING OF COMMON SHARES. * IPL PLASTICS SAYS AGREED TO ISSUE AND SELL 13.2 MILLION COMMON SHARES AT $13.50/COMMON SHARE. * IPL PLASTICS - OFFERING MADE THROUGH A SYNDICATE OF UNDERWRITERS LED BY BMO CAPITAL MARKETS, CIBC CAPITAL MARKETS AND RBC CAPITAL MARKETS.
[ Fidelity at 2018-06-21 14:29:29 ]


Thunder Bridge Acquisition Closes $225 Mln IPO

Thunder Bridge Acquisition, Ltd.(TBRGU) said Thursday that it has closed its its initial public offering of 22,500,000 units, priced at $10.00 per unit. The gross proceeds from the offering were expected to be $225 million. Ellenoff Grossman & Schole LLP acted as counsel to the Company and Graubard Miller LLP acted as counsel to the underwriters. Shares were flat in the after-hours session.
[ Fidelity at 2018-06-21 14:28:58 ]


Xeris Pharmaceuticals Shines at Debut - Rising 25% vs IPO Price

Xeris Pharmaceuticals(XERS) shares were 25% higher at $18.68 in late trade on Thursday, compared with its initial public offering price of $15.
[ Fidelity at 2018-06-21 12:22:20 ]


More IPO News >>    

[ Contact Us | About Us | Site Map ]

Copyright (c) 1998-2018 IPO Monitor. All rights reserved